13c |
# 037 |
15o-h2o pet |
PS-06-8 |
177lu-psma617 |
PS-21-3 |
177lu-psma617 radioligand therapy |
PS-18-6 |
18f-alf |
# 007 |
19f imaging |
# 268 |
19f mri |
ES-02-2 PS-11-5 PS-24-7 # 190 |
19f-cest mri |
PS-22-5 |
19f-mri |
PS-22-8 # 033 # 038 |
19f-multicolor mri |
PS-23-4 |
1h-mrs |
PS-14-3 |
2-photon microscopy |
# 101 # 105 |
3d cell cultures |
# 125 |
3d imaging |
# 010 |
3d kidney morphology |
# 085 |
3d print |
# 268 |
4d imaging |
PS-24-2 |
6-bromo-7-[11c]methyl-purine |
# 071 |
68ga |
# 203 |
68ga-cpcr4 |
# 133 |
68ga-psma |
# 253 |
68ga-psma-11 |
# 188 |
68ga-psma11 pet/ct |
PS-18-6 |
89zirconium |
# 206 |
99mtc-hdp |
# 115 |
[11c]dasb |
# 261 |
[11c]ns14492 |
# 150 |
[11c]osimertinib |
# 074 |
[11c]tariquidar |
# 076 |
[11c]thyimidine |
PS-19-2 |
[18f] mppf |
# 261 |
[18f]altanserin |
# 261 |
[18f]dpa-714 |
# 150 |
[18f]fdg |
# 159 |
[18f]fludarabine-pet |
# 072 |
[18f]fluoride |
PS-19-5 |
[18f]ns12137 |
# 081 |
aadc |
# 264 |
ab-nct |
# 251 |
abcb1 |
# 076 |
abcg2 |
# 076 |
activatable imaging probe |
PS-22-4 |
activated leukocyte cell adhesion molecule (alcam) |
PS-02-3 |
active calcification |
# 013 |
actomyosin |
PS-17-3 |
acuatic animals |
# 080 |
acupuncture |
# 138 |
acupuncture analgesia |
# 138 |
adapt |
PS-10-4 |
adc |
PS-21-6 |
adhesion molecules |
PS-02-3 |
adipose-derived stromal cells |
# 097 |
administration route |
# 005 |
administration routes |
# 208 |
affibody |
PS-21-4 # 248 |
affibody-based pet imaging |
PS-18-8 |
aging |
PS-17-4 # 044 # 147 |
albumine |
PS-03-7 |
aldehydes |
PS-22-4 |
alginate |
PS-06-6 |
allen brain |
PS-03-7 |
allen brain atlas |
# 271 |
allergic inflammation |
# 181 |
alpha-radiation |
# 121 |
aluminum- fluoride |
# 176 |
alzheimer |
PS-06-2 PS-22-8 # 081 |
alzheimer's disease |
PS-03-4 PS-17-4 |
alzheimer’s disease (ad) |
PS-10-7 |
amino acids |
PS-08-2 |
amyloid |
PS-06-2 |
amyloid imaging |
PS-22-8 |
amyotrophic lateral sclerosis |
PS-05-8 PS-14-3 |
androgen deprivation therapy |
PS-18-6 |
angiogenesis |
# 131 # 134 # 169 |
angiography |
# 139 |
angiotensin ii |
# 168 |
animal |
# 087 |
animal imaging |
# 205 |
animal model |
PS-03-8 # 088 # 143 |
anthraquinone |
PS-01-2 |
anti-angiogenic treatment |
# 241 |
anti-fibrotic drug |
# 088 |
anti-inflammatory |
PS-14-7 |
antibiotics |
PS-11-7 |
antibodies |
# 191 |
antibody |
PS-09-7 |
antibody conjugation |
# 235 |
antimicrobial peptides |
# 040 |
antiscatter grid |
# 091 |
aorta |
# 167 |
aortic aneurysm |
# 001 |
aortic dissection |
# 001 |
apoptosis imaging |
# 204 |
arousal |
PS-12-2 |
arthritis |
# 038 # 177 # 182 |
artifact |
# 090 |
artificial intelligence |
PS-12-7 |
asct-2 |
# 233 |
asthma |
# 181 |
astrocytes |
ES-01-5 |
atherosclerosis |
FS-01-1 PL-03/04-2 PS-04-3 PS-04-4 PS-04-6 PS-04-7 # 007 Array # 011 # 013 # 018 # 167 # 171 SG-01-3 Array |
atherosclerotic plaques |
PS-04-8 |
atlas |
PS-03-7 SG-04-3 |
autoimmune |
# 177 |
automated segmentation |
PS-12-7 |
automated synthesis |
# 050 |
autoradiography |
PS-08-6 |
bacterial imaging |
ES-03-1 |
bacterial infection |
PS-11-3 |
bariatric surgery |
# 034 |
barrett's esophagus |
# 102 |
bbb opening |
PS-20-5 |
beam-hardening |
# 090 |
behavioral tests |
# 259 |
behaviour |
PS-03-3 PS-14-4 |
benchmarking |
PS-09-2 |
beta cell mass |
# 034 |
beta probe |
# 163 |
beta-catenin |
ES-01-5 |
bevacizumab-800cw |
PL-06-1 PS-09-6 |
bids |
# 022 |
bilateral common carotid artery occlusion |
# 265 |
bile acid |
# 075 |
bimodal imaging |
# 114 |
bimodal nanosystems |
# 069 |
biocalatysis |
# 219 |
biodegradation |
# 212 |
biodistribution |
# 200 # 205 # 208 # 225 |
bioinformatics |
# 246 |
biological engineering |
ES-03-1 |
biological tissues |
PS-20-7 |
bioluminescence |
PS-08-7 PS-17-2 # 145 |
bioluminescence imaging |
PS-11-2 PS-14-6 PS-14-7 # 213 # 236 |
bioluminescent imaging |
# 108 |
biomarker |
# 037 # 241 |
biomaterials |
PS-06-6 |
biomedical imaging |
# 158 |
biomolecule |
# 218 |
biomolecules |
PS-24-6 |
biopolymers |
# 251 |
bioprinting |
PS-21-5 |
bioreactor |
# 219 |
bivalvia |
# 080 |
bli |
# 126 |
blood brain barrier |
FS-01-2 |
blood flow |
# 172 |
bnct |
Array Array |
bold |
PS-06-4 |
bold fmri |
# 143 |
bombesin |
# 256 |
bombesin-like peptide |
# 164 |
bone |
# 008 |
bone imaging |
# 229 |
bone metastases |
# 105 |
bone metastasis |
PS-15-8 |
boron |
# 244 |
boron neutron capture therapy |
# 208 |
brain |
PS-17-3 # 266 |
brain atlas registration |
SG-04-2 |
brain distribution |
# 071 |
brain glucose metabolism |
# 136 |
brain imaging |
# 158 |
brain injury |
PS-12-2 |
brain metastases |
PS-02-3 |
brain networks |
# 138 |
brain state |
PS-17-5 |
brain states |
PS-03-6 |
brain tumor |
# 108 |
brain waste clearance |
PS-17-5 |
brainstem ischemia |
# 262 |
breast cancer |
PS-13-3 PS-18-2 PS-18-8 PS-24-8 # 228 |
breast cancer model |
# 242 |
breast imaging |
PS-24-8 |
breast tumour metabolic activity |
# 238 |
brest cancer |
PS-15-6 |
bronchoscopy |
PS-11-3 |
brown adipose tissue |
PS-07-4 # 039 |
cad |
PS-04-7 |
calcium imaging |
PS-01-8 |
calcium phosphates |
# 005 |
calcium probes |
PS-06-3 |
calibration |
PS-09-2 |
calliper |
# 086 |
camelid single-domain ab fragments |
# 239 |
cancer |
PS-08-3 PS-08-7 PS-08-8 PS-11-6 PS-16-5 PS-21-7 # 068 # 105 # 120 SpotSymp 02-11 |
cancer cell death |
# 236 |
cancer imaging |
# 109 |
cancer immunotherapy |
PS-15-2 |
cannabinoids |
PS-17-3 |
car t cells |
PS-08-4 PS-15-6 |
car t-cells |
ES-03-1 |
carbon source |
# 120 |
carbon-11 |
PS-19-2 # 054 # 056 # 112 |
cardiac |
PS-13-8 |
cardiac activation |
# 010 |
cardiac energetics |
# 003 |
cardiac fibrosis |
# 168 |
cardiac function |
# 003 |
cardiac imaging |
# 023 |
cardiac metabolic imaging |
# 230 |
cardiac metabolism |
# 003 |
cardiac pathology |
# 170 |
cardiovascular |
PS-04-7 |
cardiovascular diseases |
# 067 |
caveolin-1 |
PS-18-3 |
ccpe |
PS-02-4 |
cd20 |
# 239 |
ceacam 1 |
# 030 |
cell adhesion molecules |
# 269 |
cell labeling |
# 061 # 206 |
cell labelling |
PS-19-8 # 209 |
cell therapy |
PS-08-7 |
cell tracking |
PS-05-7 PS-21-8 PS-23-2 # 049 # 061 # 175 # 189 # 209 # 260 |
cell uptake experiments |
# 210 |
cell-based therapy |
# 067 |
cell-tracking |
PS-22-3 |
centrifugation |
# 193 |
cerebral blood flow |
# 263 |
cerebral blood flow and volume |
PS-06-7 |
cerebral connectivity |
# 263 |
cerebral ischemia |
PS-03-8 # 150 # 263 # 267 # 272 |
cerenkov |
PS-09-3 |
cest |
PS-14-8 # 061 |
chelate |
# 194 |
chelator-free labeling |
# 060 |
chelators |
# 257 |
chemical exchange saturation transfer |
PS-22-4 |
chemoradiation |
Array Array |
chemotherapeutic drug induced apoptosis |
# 204 |
cheta |
PS-06-5 |
choline |
# 242 |
choroid plexus |
# 260 |
circulating progenitor cells |
# 067 |
circumventricular organs |
ES-01-5 |
citrate |
# 120 |
claudin-4 |
PS-02-4 |
clfa |
# 047 |
cli |
PS-09-3 |
clinical |
PS-21-6 |
clinical study |
PS-18-7 |
clinical translation |
PS-08-4 |
cloud |
# 016 |
cns |
PS-18-5 # 072 |
color mpi |
PS-19-7 |
colorectal cancer |
# 116 |
combination treatment |
PS-18-6 |
composite phantom |
PS-09-2 |
computational optics |
# 227 |
computed tomography |
# 083 # 092 |
computer-tomography |
PS-12-3 |
conditioned pain modulation |
# 143 |
confocal |
Array Array |
connexins |
# 137 |
consciousness |
PS-12-2 |
contrast agent |
PS-21-6 PS-22-4 # 195 # 201 # 229 # 268 |
contrast agents |
ES-02-4 PS-24-7 # 190 # 197 # 212 # 228 |
contrast ct |
# 084 |
contrast media |
# 202 |
controlled cortical impact |
PS-14-4 |
convex optimization |
PS-12-6 |
convolutional autoencoders |
# 021 |
coordination |
PS-01-2 |
copper-64 |
PS-10-6 |
core-crosslinked polymeric micelles |
PS-08-5 |
coregistration |
SG-04-3 |
coronary |
# 172 |
corticosterone |
# 261 |
craniosynostosis |
# 224 |
crgd peptide |
PS-09-4 |
cryptococcus |
PS-11-4 |
cryptographic timestamp |
# 026 |
csi |
# 222 |
ct |
# 086 # 087 # 090 # 115 # 180 Array Array |
ct-fmt |
PS-20-5 PS-23-6 |
curcumin |
PS-22-8 |
cxcr4 |
PS-18-5 # 133 |
cyanine dyes |
# 078 |
cytoreduction |
# 161 |
cytotoxic t cells |
PS-15-8 |
dat |
# 264 |
data curation |
# 026 |
data management |
# 016 |
data preprocessing |
# 023 |
database |
# 016 |
dce-mri |
# 130 |
de novo proteins |
ES-03-1 |
deep learning |
# 021 |
deep tissue imaging |
# 101 |
dentate nucleus |
# 265 |
depression |
# 261 |
design of experiments |
PS-19-5 |
designed bionanostructures |
ES-03-2 |
designed genetic circuits |
ES-03-2 |
designer proteins |
ES-03-1 |
detection threshold |
# 253 |
development |
# 137 |
dfo |
# 191 |
diabetes |
FS-02-2 PS-01-4 PS-07-4 |
diagnosis |
PS-02-8 # 224 |
diagnostic |
PS-18-5 # 207 |
dicect |
# 084 |
diels alder reaction |
# 257 |
diffusion |
# 153 |
diffusion tensor imaging |
PS-03-3 PS-14-4 PS-17-4 |
diffusion weighted imaging |
PS-17-5 |
directed evolution |
ES-03-1 |
distal mca occlusion |
PS-14-6 |
distribution volume |
# 020 |
divik |
# 017 |
dki |
# 153 |
dna damage response |
PS-21-3 |
dnp |
PS-13-4 |
docetaxel |
# 123 |
dopamine |
PS-06-4 # 264 |
doppler |
PS-17-3 # 169 # 172 |
doppler ultrasonography |
# 228 |
dosimetry |
PS-18-7 |
dota |
# 078 |
dota-nanogel-bombesin |
# 256 |
doxorubicin |
# 125 |
dpa-714 |
# 135 |
dreadds |
PS-17-8 |
drug carriers |
# 057 |
drug delivery |
FS-01-1 PS-11-8 # 208 |
drug delivery system |
# 198 |
drug resistance |
PS-18-4 |
drug screening platform |
PS-21-5 |
dsc-mri |
PS-06-8 |
dti |
PS-03-4 # 153 |
dti-mri |
# 262 |
dual energy radiography |
# 089 |
dual imaging |
# 056 |
dual-energy calibration |
# 089 |
dual-energy decomposition |
# 089 |
dual-energy substraction |
# 089 |
duramycin |
# 204 |
dyes |
# 052 |
dynamic imaging |
# 098 |
dynamic mrsi |
PS-13-3 |
dynamic pet |
PS-05-3 PS-12-5 |
eae |
PS-14-8 |
eae monophasic model |
# 146 |
early detection |
PS-09-8 |
echo state network |
# 019 |
ecm |
PS-23-6 |
egfr |
PS-21-4 # 074 |
elastin |
PS-04-3 # 012 # 173 |
elastography |
# 228 |
electron microscopy |
PS-19-6 |
electronic laboratory notebook |
# 016 |
elemental imaging |
PS-20-7 |
emission spectrum |
# 213 |
encapsulins |
PS-19-6 |
endocarditis |
# 046 # 047 |
endocytosis |
PS-18-3 |
endomicroscopy |
PS-20-2 |
endoscopy |
PS-20-2 # 227 SpotSymp 02-4 |
endothelial dysfunction |
# 171 |
energetics |
FS-02-2 |
epidermal growth factor receptor |
PS-16-5 |
epilepsy |
PS-17-7 |
epithelial ovarian cancer |
# 161 |
epsi |
# 222 |
esophagus imaging |
# 226 |
estrogen |
PS-17-4 |
eurobioimaging |
EuBI-1 |
european research infrastructure consortium |
EuBI-1 |
europium |
# 187 |
ex vivo |
PS-16-7 # 266 |
ex vivo staining |
# 085 |
exendin |
PS-10-2 PS-18-7 # 111 |
exercise |
# 142 |
expansion microscopy |
PS-20-4 |
experimental animal model |
PS-14-5 |
experimental arthritis |
PS-23-5 |
fast field cycling relaxometry |
# 238 |
faza |
# 031 # 247 |
fcfm |
PS-11-3 |
fdg |
PS-14-3 # 013 # 157 # 242 # 243 |
fdg-pet |
# 004 # 136 # 241 |
feature selection |
PS-12-3 |
females |
# 152 |
fet |
PS-09-3 PS-21-6 # 149 # 247 |
fetal development |
ES-01-3 |
fetal echocardiography |
# 170 |
fibrosis |
PS-01-7 PS-23-8 |
file format |
# 026 |
flavonoid |
# 201 |
flect |
# 109 |
fluorescence |
PS-01-4 PS-04-7 PS-06-3 PS-09-7 PS-16-6 PS-16-7 PS-23-4 PS-24-7 # 068 # 161 # 187 # 202 Array Array SpotSymp 02-4 |
fluorescence and confocal microscopy |
PS-20-5 |
fluorescence imaging |
PS-09-8 PS-11-3 PS-24-4 # 114 # 205 # 240 SpotSymp 02-2 |
fluorescence microscopy |
# 052 |
fluorescence molecular tomography |
# 098 |
fluorescence-guided surgery |
# 165 |
fluorescent histochemistry |
# 134 |
fluorescent microspheres |
PS-05-3 |
fluorescent molecular tomography |
# 116 |
fluorescent proteins |
# 134 |
fluoride-18-pet |
# 121 |
fluorination |
# 190 |
fluorine |
PS-21-7 # 195 |
fluorine mri |
PS-08-8 |
fluorine-18 |
# 176 |
fluoro 18 labeling |
# 075 |
fmri |
PS-06-5 # 138 |
foreign substances |
PS-20-7 |
fractional elution |
# 050 |
frames |
PS-12-5 |
fri |
PL-06-2 |
ftir |
PS-05-8 |
functional connectivity |
PS-12-2 PS-17-6 PS-17-7 # 138 |
functional recovery |
# 271 |
functional ultrasound |
PL-02-2 |
fungal infection |
PS-11-4 |
fungal infections |
# 048 |
fus imaging |
PL-02-2 |
ga-68 |
PS-10-2 PS-10-4 # 182 |
ga68 |
PS-05-3 |
gadodiamide |
# 265 |
gadolinium |
# 070 # 106 # 194 # 195 |
gadolinium deposition |
# 265 |
galectin-3 |
PS-04-8 |
gallium-68 |
PS-10-6 # 176 |
gallium-68 ubiquicidine |
# 050 |
gastrin releasing peptide receptor (grpr) |
# 164 |
gbm |
# 031 |
gelofusine |
PS-18-7 |
gemcitabine |
# 130 |
gender analysis |
# 147 |
genetic circuits |
ES-03-1 |
gentate gyrus |
PS-20-4 |
glioblastoma |
PS-09-3 PS-21-4 # 035 # 125 # 247 |
glioma |
PS-21-6 # 149 |
glioma associated-inflammation |
PS-14-2 |
global hypoperfusion |
# 033 |
glp-1 imaging |
# 034 |
glp-1 receptor |
PS-18-7 # 111 |
glucose |
PS-14-8 PS-24-6 |
glucose utilization |
PS-07-8 |
glutamate fmri |
PS-22-6 |
glycogen |
# 198 |
glycolytic shift |
PS-07-3 |
glymphatic system |
PS-17-5 |
gold |
# 212 |
gold nanoparticles |
ES-02-2 PS-10-6 # 083 # 190 |
gold nanoparticules |
PS-05-7 |
gold nanorods |
Array Array |
gpiib/iiia |
# 109 |
graph theory |
# 138 # 141 # 144 |
graphical user interface |
# 023 |
green chemistry |
# 201 |
guided resection |
SpotSymp 02-4 |
haemophilia |
# 100 |
half-life |
PS-15-5 |
hand-held probes |
SpotSymp 02-8 |
head and neck cancer |
PS-09-7 |
heart |
FS-02-2 |
heart dysfunction |
PS-13-5 |
heart failure |
FS-02-2 # 002 |
hemodynamics |
PS-03-8 |
hemorrhage |
# 184 |
her2 |
PS-02-6 PS-10-4 PS-18-3 # 248 |
her3 |
PS-10-5 PS-18-8 |
heteromultivalent |
# 131 |
hibit |
# 041 |
high resolution |
PS-13-6 |
high throughput |
# 157 |
hind limb ischemia |
# 169 |
hippocampus |
# 265 |
histology |
# 021 # 153 SG-04-2 |
histopathology |
# 271 |
host response |
# 044 |
host:guest |
PS-22-5 |
hpa-axis |
# 261 |
hsp90 |
# 112 |
hsp90 inhibition |
PS-18-8 |
human blood |
# 106 |
human epidermal growth factor 3 |
PS-10-5 |
human fetal brain |
# 137 |
human papillomavirus |
PS-11-2 |
human paraffin samples |
PS-20-7 |
hybrid |
PS-04-7 |
hybrid system |
PS-24-4 |
hybrid tracers |
PS-09-4 |
hydrogel |
PS-21-5 # 145 |
hyperinsulinemia |
# 030 |
hyperpolarised |
# 221 |
hyperpolarization |
PS-13-2 PS-13-3 PS-13-4 PS-13-5 # 218 # 222 |
hyperpolarized 13c-mrs |
# 038 |
hyperthermia |
# 193 |
hypoxia |
PS-07-3 PS-07-8 PS-15-8 # 231 |
iacs-010759 |
# 031 |
icg |
# 175 |
idisco |
PS-03-7 |
iedda |
# 186 |
image analysis |
PS-12-7 PS-23-8 |
image contrast |
PS-19-7 |
image guided drug delivery |
FS-01-2 |
image guided surgery |
# 161 SpotSymp 02-7 SpotSymp 02-11 |
image guided therapies |
ES-03-1 |
image reconstruction |
PS-12-6 PS-19-7 # 024 # 098 |
image registration |
# 271 |
image-guided pathology |
PS-09-6 |
image-guided surgery |
PS-09-5 SpotSymp 02-2 |
image-guided therapy |
Array Array |
imaging |
PS-04-7 PS-08-3 PS-11-5 PS-24-7 # 002 # 070 # 072 # 088 # 212 # 224 Array Array |
imaging biomarker |
PS-23-6 |
imaging features |
# 015 |
imaging mass spectrometry |
PS-20-6 |
imaging of viral infection |
# 041 |
imaging probes |
ES-02-2 |
imaging technology |
EuBI-1 |
immune cell metabolism |
PS-07-5 |
immune cells |
PS-11-5 |
immune checkpoints |
PS-07-5 |
immuno-pet imaging |
PS-02-8 |
immunohistochemistry |
# 001 |
immunology |
PS-11-6 |
immunosuppression |
PS-11-5 |
immunotherapy |
PS-07-5 PS-08-4 PS-08-8 PS-15-5 PS-15-6 |
in ovo tumor model |
# 117 |
in situ vaccine model |
PS-15-2 |
in vitro and in vivo studies |
# 236 |
in vitro imaging |
# 235 |
in vivo |
PL-06-2 PS-01-8 PS-13-3 # 100 |
in vivo imaging |
PS-23-4 # 155 # 235 |
in-111 |
PS-10-4 # 189 |
infection |
# 046 # 047 # 049 |
infectious diseases |
PS-11-5 |
inflammation |
ES-01-3 PS-11-6 PS-14-4 # 013 # 147 # 167 # 177 |
insulin |
PS-07-4 |
insulinoma |
PS-18-7 # 111 |
insulinomas |
PS-10-2 |
integrin |
# 116 |
integrin avb3 |
# 182 |
integrin αvβ3 |
# 165 |
interactive |
# 022 |
intestine tumor |
# 116 |
intra-operative fluorescence imaging |
PS-09-2 |
intra-operative imaging |
# 163 SpotSymp 02-8 |
intracellular calcium imaging |
PS-22-7 |
intracellular water lifetime |
# 238 |
intraoperative |
PS-09-3 |
intraoperative imaging |
PS-09-8 # 162 |
intrathecal delivery of cells |
PS-06-6 |
intratumor biology |
PS-20-2 |
intravascular |
PS-04-7 |
intravital imaging |
PS-20-2 |
intravital microscopy |
PS-11-6 PS-15-8 # 105 |
intrinsic signal |
# 019 |
invasive pulmonary aspergillosis |
# 048 |
iodine-125 |
# 080 |
iodine-131 |
PS-02-6 |
ion |
PS-22-3 |
ionophores |
# 209 |
irinotecan |
# 249 |
iron |
# 194 |
iron oxide nanoparticles |
# 096 # 199 # 236 |
iron oxides |
# 200 |
iron-quantification |
PS-22-3 |
iron-quercetin complex. |
# 067 |
irradition |
# 247 |
ischemic stroke |
# 259 |
iterative methods |
# 024 |
jupyter notebook |
# 022 |
k-edge imaging |
PS-05-6 PS-05-7 |
kidney fibrosis |
PS-23-6 |
kinetic inertness |
PS-19-8 |
kinetic modelling |
PS-21-6 |
kit radiolabeling |
# 188 |
kit-based labelling |
# 186 |
label-free |
PL-06-3 PS-24-6 |
labelled heterocycles |
# 054 |
lactate |
# 035 # 038 |
lanthanide |
PS-01-2 |
lanthanide complexes |
# 061 |
lanthanides |
PS-19-8 |
laser |
# 169 |
laser-induced breakdown spectroscopy (libs) |
PS-20-7 |
lectine |
PS-03-7 |
lentiviral particles |
PS-14-7 |
lgbit |
# 041 |
light activation |
# 063 |
light sheet fluorescence microscopy (lsfm) |
# 125 |
light sheet microscopy |
PS-20-4 |
limbic encephalitis |
# 135 |
limited-angle |
# 092 |
linearization |
# 090 |
lipid metabolism |
PS-07-6 |
lipids |
PS-24-6 |
liposomal nanomedicines |
# 209 |
liposome |
# 249 |
liposomes |
# 229 |
live-cell microscopy |
PS-24-6 |
liver |
# 075 # 076 |
liver fibrosis |
# 183 |
liver inflammation |
# 183 |
liver tumour therapy |
PS-05-6 |
local administration |
# 215 |
localized heating |
Array Array |
locally advanced rectal cancer |
PS-09-6 |
locus coeruleus |
# 081 |
long term monitoring |
PS-16-6 |
longitudinal study |
PS-05-6 |
lps |
# 147 |
lsfm |
PS-17-2 |
lu-177 |
PS-08-6 |
luciferase |
# 145 # 213 |
luminescence |
PS-01-2 PS-15-5 |
lung |
# 087 # 217 |
lung administration |
# 159 |
lung fibrosis |
# 088 |
lung imaging |
PS-05-5 PS-11-8 # 040 |
lung inflammation |
# 043 |
lymph node |
PS-09-7 |
lymph nodes |
# 184 |
lymphatic endothelial cell |
ES-01-2 |
lymphatic valve |
ES-01-2 |
lymphatic vessel |
ES-01-2 |
lymphoma |
PS-18-5 # 072 # 243 |
machine learning |
PS-12-4 PS-12-7 # 021 |
macrophage |
PS-21-7 |
macrophages |
# 043 # 096 |
magnetic fluid hyperthermia |
Array Array |
magnetic hyperthermia |
# 236 |
magnetic nanoparticle |
# 069 |
magnetic nanoparticles |
PS-11-8 PS-13-6 Array Array |
magnetic particle imaging |
PS-06-7 PS-11-8 PS-12-6 PS-13-6 PS-19-7 # 049 # 066 # 184 # 216 # 217 Array Array |
magnetic resonance imaging |
PS-03-8 PS-14-6 PS-14-7 # 003 # 202 # 199 # 260 # 265 |
magnetic resonance imaging (mri) |
# 152 |
magnetic resonance spectroscopy |
FS-02-2 |
magnetic resonance spectrsocopy |
# 003 |
magnetogenetics |
ES-03-1 |
maldi |
# 017 |
maldi-ms |
PS-20-6 |
manganese |
PS-06-6 |
manganese-enhanced magnetic resonance imaging |
# 141 |
mannan |
# 068 |
maprang |
# 201 |
mass cytometry |
# 106 |
material decomposition |
# 082 |
maternal immune activation |
PS-03-3 |
maternal immune stimulation (mis) |
# 152 |
matrix metalloproteases |
# 148 |
matrix metalloproteinases |
PS-03-8 |
mcao |
# 139 |
me-bssfp |
# 222 |
medical diagnostics |
PS-20-7 |
melanoma |
PS-21-8 # 031 # 112 |
menopause |
PS-17-4 |
mercury arc lamp |
# 104 |
mesoscopic tomography |
PS-16-6 |
mesothelin |
PS-02-5 |
metabolic connectivity |
PS-07-7 |
metabolic disease |
# 018 |
metabolic heterogeneity |
PS-12-4 |
metabolic imaging |
# 221 # 222 |
metabolism |
FS-02-2 PS-07-8 # 037 |
metabolite profiling |
# 035 |
metabolomics |
PS-07-3 PS-08-3 # 177 |
metallacrown |
PS-01-2 |
metastases targeting |
PS-08-5 |
metastasis |
# 177 # 207 |
metastatic clear-cell renal carcinoma |
# 015 |
mice |
# 142 # 272 |
micro-algae |
# 080 |
micro-ct |
PS-23-8 # 002 # 023 # 030 # 088 # 100 |
microbubble |
FS-01-1 |
microcoil |
# 035 |
microct |
# 168 |
microdialysis |
# 035 |
microglia |
# 148 |
microglia/ macrophages |
PS-14-7 |
microparticles of iron oxide (mpio) |
PS-02-3 |
microscopic resolution |
PS-24-3 |
microscopy |
PL-06-3 # 224 |
microvasculature |
# 008 |
mid-infrared |
PS-24-6 |
migration |
PL-06-2 |
mineralization |
# 167 |
minocycline |
# 012 |
molecular |
PS-04-7 |
molecular actuators |
ES-03-1 |
molecular fluorescence endoscopy |
PL-06-1 |
molecular fluorescence guided surgery |
# 246 |
molecular imaging |
PS-02-4 PS-04-4 PS-04-6 PS-10-5 PS-19-7 # 173 # 246 |
molecular mri |
PS-22-5 |
molecular sensors |
ES-03-1 |
molecular targeting |
# 165 |
monocytes |
PL-06-2 |
monolithic crystals |
# 156 |
motion correction |
# 230 |
mouse |
# 169 # 271 SG-04-2 |
mouse brain |
PS-17-6 |
mouse model |
PS-11-2 # 031 # 046 # 240 # 253 |
mouse model of breast cancer |
PS-16-6 |
mpi |
# 066 # 193 |
mr angiography |
# 268 |
mr relaxometry |
# 057 |
mr-phantom |
# 268 |
mra. |
# 139 |
mri |
PS-02-3 PS-04-3 PS-06-6 PS-07-4 PS-07-6 PS-08-7 PS-13-4 PS-14-5 PS-14-8 PS-19-6 PS-21-7 PS-22-3 PS-23-6 # 004 # 011 # 012 # 039 # 046 # 047 # 061 # 068 # 070 # 096 # 098 # 106 # 142 # 146 # 150 # 153 # 167 # 173 # 183 # 187 # 189 # 193 # 194 # 195 # 197 # 200 # 201 # 211 # 218 # 219 # 259 # 263 # 266 # 272 SG-04-2 |
mri and mrs |
# 035 |
mri contrast agent |
# 067 |
mri contrast agents |
PS-22-7 # 069 |
mri data processing |
# 022 |
mri-cest |
# 045 |
mrp4 |
# 071 |
mrsi |
# 221 |
msi |
# 017 |
msot |
PS-01-8 |
mtbi |
# 153 |
multi component reaction |
# 063 |
multi-modal fmri |
PS-22-6 |
multi-parametric analysis |
# 259 |
multicolored imaging |
PS-22-5 |
multiligand |
# 131 |
multimodal |
PL-06-3 PS-06-4 PS-08-7 # 056 # 197 |
multimodal contrast agent |
# 202 |
multimodal imaging |
PS-11-4 # 026 # 048 # 078 # 126 # 162 # 198 |
multimodal probe |
# 211 |
multimodality |
ES-02-3 PS-24-4 |
multimode fibers |
# 227 |
multiparametric |
PS-21-6 |
multiphoton fluorescence imaging |
# 099 |
multiple myeloma |
# 133 |
multiple sclerosis |
PS-14-8 # 146 # 270 |
multispectral optoacoustic imaging |
PS-03-8 |
multispectral optoacoustic tomography |
PS-01-8 |
murine models |
PS-11-4 |
myelin |
PS-06-2 # 270 |
myocardial infarction |
PL-06-2 # 004 |
naf |
# 013 |
naked mole rat |
PS-07-8 |
nano-radiotracer |
# 043 |
nanobodies |
# 007 # 108 |
nanobody |
PS-04-6 # 269 |
nanobubbles |
FS-01-3 |
nanocarriers |
# 040 |
nanocompartments |
PS-19-6 |
nanoemulsion |
# 244 |
nanogels |
# 256 |
nanoluc luciferase |
# 041 |
nanomaterial |
PS-01-2 |
nanomedicine |
ES-02-3 PS-20-5 |
nanomicelles |
# 011 |
nanoparticle |
PS-08-7 |
nanoparticles |
ES-02-3 PS-13-4 PS-20-6 PS-24-7 # 005 # 057 # 070 # 115 # 131 # 171 # 202 # 197 # 200 # 212 # 240 Array Array |
nanosystem |
Array Array |
nanotherapy |
# 040 |
nanotracer |
# 207 |
near infrared guided surgery |
# 164 |
near infrared probe |
PS-01-7 |
near-infrared |
PS-01-2 PS-01-4 PS-04-7 PS-09-7 # 095 # 215 |
near-infrared fluorescence |
PS-09-6 |
near-infrared fluorescence imaging |
PS-09-4 |
near-infrared imaging |
ES-02-4 |
nebulisers |
# 159 |
needle guiding |
# 162 |
negishi reaction |
PS-19-2 |
nema protocol |
PS-05-2 |
neural stem cells |
PS-17-2 |
neuro-imaging |
PS-24-2 |
neurobehavioral |
PS-06-3 |
neurodegeneration |
# 081 |
neuroimaging |
PL-02-2 PS-03-5 PS-10-7 |
neuroinflammation |
# 018 # 146 # 150 # 260 # 263 # 269 |
neuron-glia-vessel network |
PS-22-6 |
neurons |
# 137 |
neuroplasticity |
PS-17-6 |
neuropsychiatric |
# 081 |
neurovascular imaging |
PS-06-7 |
neutrophils |
# 043 |
new probe |
PS-24-2 |
nfkb |
PS-01-4 |
nir |
# 095 # 161 |
nis |
PS-21-8 |
nmda receptor |
PS-03-3 |
nmr |
PS-07-3 PS-07-6 # 037 |
non-alcoholic fatty liver disease |
PS-07-6 |
non-coherent illumination source |
# 104 |
non-invasive |
PS-18-4 PS-23-6 |
non-invasive imaging |
PS-04-8 PS-08-5 |
non-invasive intra-vital imaging |
PS-16-6 |
non-invasive technics |
# 114 |
noninvasive |
# 213 |
norepinehrine transporter |
# 081 |
nsclc |
# 074 |
nuclear imaging |
ES-02-3 # 108 # 155 # 205 SG-01-3 SpotSymp 02-8 |
oct |
# 096 |
odnp |
PS-13-2 |
oncology |
PS-02-2 # 243 |
open access |
EuBI-1 |
opt |
# 095 |
optical |
Array Array SpotSymp 02-4 |
optical imaging |
PS-01-2 PS-09-8 PS-11-7 PS-16-5 # 087 # 100 # 165 # 248 |
optical in vivo imaging |
# 116 |
optical molecular imaging |
# 041 # 102 |
optical-pet |
# 056 |
optoacoustic |
PL-06-3 PS-18-2 |
optoacoustic imaging |
PS-16-3 PS-24-3 PS-24-4 # 226 # 231 # 237 |
optoacoustic microscopy |
# 008 |
optoacoustics |
PS-01-8 PS-24-8 |
optogenetic |
PS-06-5 |
optogenetics |
ES-03-1 |
organ toxicity |
# 204 |
orthotopic xenograft |
PS-02-8 |
osteosarcoma |
# 121 |
ovarian cancer |
PS-16-3 PS-18-4 |
ox40 |
PS-15-2 |
oxidation specific epitopes |
PS-04-4 |
oxidative damage |
# 210 |
oxidative phosphorylation |
# 031 |
oximetry |
PS-08-8 |
oxygen |
PS-06-4 |
oxygenation |
# 033 |
palm |
# 104 |
pancreatic cancer |
PS-02-4 PS-12-4 |
papillary thyroid cancer |
# 246 |
paracest |
PS-19-8 |
paraganglioma |
# 241 |
parahydrogen |
# 218 |
parkinson |
# 264 |
parp |
PS-08-2 |
parp1 |
PS-09-8 |
passive accumulation |
# 165 |
patlak plot |
PS-12-5 |
pbif |
# 020 |
pd-l1 |
PS-15-3 |
pdac |
# 130 |
peg |
# 052 |
pegylation |
# 199 |
penncentury microsprayer |
# 159 |
perfluorocarbon |
PS-08-8 # 038 |
perfluorocarbon emulsions |
# 033 |
perfluorocarbons |
PS-23-4 |
performance evaluation |
# 163 |
perfusion |
# 217 |
perfusion imaging |
PS-06-8 |
perfusion mri |
# 183 |
personalised medicine |
PL-06-1 |
pertussis |
PS-11-3 |
pet |
ES-02-3 PS-02-2 PS-03-2 PS-05-3 PS-07-3 PS-10-2 PS-10-4 PS-10-6 PS-10-7 PS-15-5 PS-15-6 PS-18-5 # 018 # 020 # 024 # 031 # 039 # 071 # 074 # 075 # 081 # 109 # 150 # 155 # 167 # 209 # 233 # 243 # 244 # 247 # 263 # 264 # 267 SpotSymp 02-8 |
pet imaging |
PS-08-2 PS-09-4 PS-14-2 PS-16-5 PS-18-3 # 007 # 043 # 111 # 147 # 157 # 203 |
pet insert |
# 156 |
pet probe |
Array Array |
pet tracer |
# 210 |
pet-ct |
# 204 |
pet-imaging |
# 176 |
pet-mr |
PS-14-3 |
pet-mri |
PS-06-8 PS-13-8 # 060 # 126 # 135 |
pet/ct |
PS-12-4 # 235 # 253 |
pet/ct imaging |
# 188 |
pet/mri |
PS-04-4 PS-04-6 PS-21-6 # 117 |
ph |
# 045 |
ph sensors |
PS-13-3 |
pharmacokinetics |
PS-12-5 # 215 |
pharmacological mri |
PS-03-3 |
phase i trial |
# 121 |
phase-contrast imaging |
PS-05-5 |
photo-bleaching |
# 052 |
photoacoustic |
PL-06-3 PS-18-2 PS-24-7 # 202 # 212 # 224 # 225 |
photoacoustic imaging |
PS-24-3 # 175 # 211 # 229 |
photoacoustics |
PS-01-8 PS-24-6 PS-24-8 # 227 |
photocleavage |
# 063 |
photodynamic therapy |
PS-23-5 # 237 SpotSymp 02-7 |
photoimmunotherapy |
PS-21-4 # 248 |
photon counting computed tomography |
PS-05-6 |
photon-counting |
# 082 |
photopharmacology |
PS-11-7 |
phthalocyanine |
# 211 |
pipeline framework |
# 022 |
pk11195 |
# 018 |
platelets |
ES-01-3 PS-04-5 # 109 |
plga |
# 189 |
poly i:c acid |
# 152 |
polyamidoamine dendrimer |
PS-01-2 |
polyaminocarboxylate |
PS-01-2 |
polymer nanoparticles |
# 208 |
polymersomes |
Array Array |
positron emission tomography |
PS-14-4 PS-15-2 PS-18-4 # 076 # 148 # 149 # 230 |
positron emission tomography (pet) |
# 152 # 158 |
post-gastric bypass hypoglycemia |
# 034 |
pre-clinical imaging |
SG-01-3 |
pre-clinical study |
PS-23-2 |
preclinical |
PS-18-4 # 082 |
preclinical drug screening |
# 125 |
preclinical evaluation |
PS-10-5 |
preclinical imaging |
# 249 |
preclinical research |
# 155 |
preclinical trials |
PS-08-4 |
predict response |
PS-18-4 |
prediction |
# 019 |
pretargeting |
PS-18-3 # 191 # 257 |
primary cell cultures |
# 125 |
pro-inflammatory |
PS-14-7 |
probabilistic mapping |
# 262 |
probe development |
PS-03-2 |
probe-based confocal laser endomicroscopy |
# 097 |
probes |
# 108 |
prognostic biomarkers |
PS-14-4 |
progression |
# 231 |
progressive supranuclear palsy (psp) |
PS-10-7 |
prostate |
# 120 |
prostate cancer |
FS-01-3 PS-08-6 PS-09-5 PS-10-6 PS-18-6 PS-21-3 # 114 # 123 # 164 # 188 # 233 # 240 # 253 |
protein corona |
ES-02-2 # 011 |
protein engineering |
ES-03-1 |
protein loading |
# 219 |
proteins |
PS-24-6 |
proteomics |
PS-08-3 # 177 |
prrt |
PS-18-7 # 117 |
psma |
PS-08-6 PS-09-5 PS-18-6 PS-21-3 # 123 # 188 # 253 |
pulmonary |
# 217 |
pulmonary blood flow |
PS-05-3 |
pulmonary fibrosis |
# 180 |
pulmonary hypertension |
PS-07-3 # 002 |
pulmonary infection |
# 082 |
pulse sequence design |
# 216 |
pulsed excitation |
# 216 |
pyruvate metabolism |
PS-13-5 |
python |
# 022 |
quantification |
PS-15-3 # 020 |
quantitative analysis |
# 085 |
quantitative imaging |
SpotSymp 02-2 |
quantitative susceptibility mapping |
# 272 |
quantum dots |
# 069 |
ra-223 treatment |
# 121 |
radiation dose |
PS-18-7 |
radiation necrosis |
PS-08-2 |
radio ligand therapy |
# 253 |
radiochemistry |
PS-19-5 |
radiography |
# 091 |
radioguided surgery |
SpotSymp 02-8 |
radiolabeled exendin |
PS-18-7 |
radiolabeling (i-124) |
Array Array |
radiolabelling methods |
# 054 |
radioligand therapy |
PS-21-3 |
radiomics |
PS-12-3 PS-12-7 # 015 # 121 |
radionuclide imaging |
# 080 SpotSymp 02-7 |
radiopharmaceuticals |
# 256 |
radiosensitizer |
Array Array |
radiotherapy |
PS-15-3 Array # 210 Array |
radiotracer |
PS-02-8 # 270 |
raman |
SpotSymp 02-4 |
rat |
# 262 |
rat model |
# 004 |
rat strains |
# 139 |
real-time imaging |
PS-24-3 |
rectal cancer |
PL-06-1 |
regenerative medicine |
# 145 |
regulatory t cells |
PS-23-2 |
relaxation mapping |
# 216 |
relaxometry |
PS-19-8 |
remodeling |
# 012 |
renal fibrosis |
# 085 |
renal retention |
PS-10-2 |
repebody |
PS-16-5 |
reporter gene imaging |
PS-21-8 |
reporter genes |
ES-03-1 PS-19-6 |
reproducibility |
# 015 # 026 |
resistance formation |
# 123 |
resonance raman scattering |
# 099 |
response evaluation |
# 121 |
responsive mri probes |
# 063 |
resting state |
# 138 # 143 |
resting state fmri |
PS-17-7 # 141 |
resting state functional mri |
PS-17-8 |
resting state networks |
# 141 |
resting-state fmri |
PS-07-7 PS-17-6 # 144 |
resting-state functional mri |
PS-03-3 |
retrospective gating |
PS-13-8 # 023 |
reversible sensor |
PS-01-8 |
rgd |
# 182 |
rheumatoid arthritis |
PS-23-5 |
rodent |
# 264 |
rodent model |
# 100 |
rs-fmri |
PS-03-6 |
rsfmri |
PS-03-4 |
s. aureus |
# 046 |
s. aureus skin infection |
# 044 |
sabre |
PS-13-2 |
salvinorin b |
PS-17-8 |
scanner design |
# 158 |
scatter |
# 091 |
scattering |
# 095 |
schizophrenia |
PS-03-3 # 152 |
scintigraphic/x-ray imaging |
# 005 |
sdabs |
PS-02-5 # 124 |
second harmonic generation (shg) |
# 101 |
selfd |
# 203 |
senescence |
PS-02-2 |
sensitivity |
# 205 |
sentinel lymph node biopsy |
# 060 |
sentinel lymph nodes |
# 068 |
sepsis |
# 045 |
shear stress |
ES-01-2 |
siglec-9 |
# 176 |
signal encoding |
# 216 |
silica-induced pulmonary fibrosis |
# 178 |
silicon |
PS-13-4 |
simultaneous pet/ct-uui system |
PS-05-2 |
simultaneous pet/mri |
PS-07-7 |
single molecule localisation microscopy |
# 104 |
single-domain antibody fragment |
PS-02-6 |
single-vessel fmri |
# 019 |
site-specific conjugation |
# 235 |
skin cancer |
# 231 |
skull |
# 008 |
skull & brain imaging |
# 084 |
slow fluctuation |
# 019 |
slow oscillations |
PS-03-6 |
small animal |
PS-06-5 |
small animal pet |
# 242 |
small-scale |
PS-08-6 |
soft-tissue metastases |
# 121 |
sonoporation |
FS-01-2 PS-20-5 |
sparse subsampling |
PS-12-6 |
spatial learning |
PS-17-6 |
spect |
ES-02-3 PL-06-2 PS-02-4 PS-10-5 PS-15-3 # 060 # 115 # 207 Array # 257 # 269 Array SpotSymp 02-8 |
spect imaging |
PS-02-5 # 124 |
spect/ct |
PS-08-7 PS-21-8 # 117 |
spect/ct imaging |
PS-23-2 |
spect/pet |
# 189 |
spectral photon counting computed tomography |
PS-05-7 |
spectral-ct |
# 082 |
spectroscopic imaging |
# 221 |
spin scavenger |
# 210 |
spio |
PS-22-3 # 060 # 066 |
spion |
# 193 |
spontaneous metastasis |
# 249 |
squid |
PS-13-2 |
standardization |
PS-09-2 |
staphylococcus |
# 047 |
sted |
# 104 |
sted nanoscopy |
PS-20-5 |
stem cell differentiation |
PS-17-2 |
stem cell vitality |
PS-14-6 |
stem cells |
# 037 # 175 |
sterile skin inflammation |
# 176 |
storm |
# 104 |
strain |
PS-17-3 |
stroke |
PS-06-7 PS-06-8 PS-14-5 PS-14-7 # 139 # 148 # 262 # 266 # 271 SG-04-2 |
stroke model |
PS-14-6 |
subcutaneous |
# 215 |
sugen-hypoxia |
# 002 |
super-resolution microscopy |
PS-20-4 # 104 # 171 |
superparamagnetic iron oxide nanoparticles |
# 066 |
superresolution |
PL-02-2 |
support vector machine |
# 141 |
sustained release |
# 215 |
suv |
# 020 |
synchrotron |
# 266 |
synchrotron-based spectro-microscopy |
PS-05-8 |
synthetic biology |
ES-03-1 ES-03-2 PS-19-6 |
systemic sclerosis |
PS-23-8 |
t cells |
PS-15-2 # 206 |
t-cell therapy |
ES-03-1 |
t1 |
# 183 |
t1 contrast agents |
# 199 |
t1 longitudinal relaxation time |
# 238 |
t1 mapping |
# 033 |
t2 |
PS-03-7 |
t2-mapping |
PS-22-3 |
t2w-mri |
# 267 |
target module |
PS-15-5 |
targeted delivery |
ES-02-4 Array Array |
targeted photodynamic therapy |
PS-09-5 |
targeted radionuclide therapy |
PS-02-6 |
tau |
PS-10-7 |
tbi |
# 153 |
tco |
# 191 |
tct automated manufacturing |
PS-08-4 |
tdp-43 |
PS-14-3 |
temozolomide |
# 125 |
temporal lobe epilepsy |
# 144 |
texture analysis |
PS-12-3 |
texture features |
PS-12-4 |
tg2576 mice |
PS-17-4 |
tgf344-ad rat model |
PS-03-4 |
theranostic |
# 239 |
theranostic nanoparticles |
PS-16-3 |
theranostics |
ES-03-1 PS-02-6 PS-04-5 PS-11-7 # 063 # 068 Array Array |
therapy |
# 070 # 130 # 244 Array Array |
therapy monitoring |
PS-07-5 # 243 |
therapy response validation |
# 117 |
thermoresponsive polymer |
# 057 |
thermosensitive liposomes |
Array Array |
thiazole |
# 054 |
thiocyanate |
# 054 |
thp |
# 182 |
thrombus |
PS-04-5 |
thyroid cancer |
PS-02-8 |
tnbc |
# 249 |
tof-mra |
PS-03-7 |
tomography |
PS-05-8 PS-24-8 |
tool |
# 017 |
topical staining |
PS-09-8 |
toxicology |
# 194 |
trace elements |
PS-05-8 |
tracer |
SpotSymp 02-7 |
tracer development |
PS-19-5 |
tracking microscopes |
PS-06-3 |
transition metal complex |
# 056 |
translational |
PS-16-7 |
transplantation |
PS-23-2 |
traumatic brain injury |
PS-14-4 # 184 |
triggered radiosensitizer delivery |
Array Array |
triglyceride rich lipoprotein |
PS-07-4 |
triple negative breast cancer |
PS-08-5 # 099 # 124 |
triple-negative-breast-cancer |
PS-02-5 |
tropoelastin |
PS-04-3 # 173 |
tspo |
PS-14-2 # 149 |
tspo-pet |
# 146 |
tuberculosis |
PS-12-3 # 082 |
tumor |
FS-01-1 # 068 # 198 Array Array |
tumor angiogenesis |
PS-21-5 |
tumor biomarkers |
PS-08-5 |
tumor cellularity and perfusion |
# 130 |
tumor heterogeneity |
# 021 |
tumor imaging |
# 115 |
tumor immunology |
PS-11-6 |
tumor localization |
# 114 |
tumor microenvironment |
# 126 |
tumor targeting |
# 131 # 197 |
tumor vascularization |
# 237 |
tumor xenografts |
# 126 |
tumor-on-a-chip |
PS-21-5 |
tumour |
# 086 # 087 |
tumour size imaging |
PS-05-6 |
two-photon laser scanning microscopy. |
# 168 |
type 2 diabetes mellitus |
# 034 |
ultrafast |
# 172 |
ultrafast ultrasound |
PL-02-2 |
ultrafast ultrasound imaging |
PS-17-3 # 010 # 230 |
ultrafast ultrasounds |
PS-24-2 |
ultrasound |
FS-01-1 FS-01-2 FS-01-3 PL-02-2 PS-03-5 PS-04-5 PS-04-7 # 109 # 212 # 225 # 228 |
ultrasound biomicroscopy |
# 008 |
ultrasound imaging |
# 114 # 172 |
ultrasound localization microscopy |
PL-02-2 |
ultrawide bandwidth |
# 226 |
unicar |
PS-15-5 |
urinary excretion |
# 071 |
us imaging |
# 240 |
uspio |
# 260 |
uui |
# 241 |
uv activation |
# 104 |
vap-1 |
# 176 |
vascular biology |
ES-01-3 |
vascular cognitive impairment |
# 033 |
vascular development |
# 134 |
vascular heterogeneity |
ES-01-1 |
vascular imaging |
SG-04-3 |
vascularized composite allostransplantation |
# 097 |
vasculature |
PS-03-7 |
vbm |
# 142 |
vcam-1 |
# 124 # 269 |
vectorization |
# 251 |
ventilation |
# 217 |
virtual histology by micro computed tomography |
# 085 |
visceral fat |
# 030 |
visible light |
PS-11-7 |
voltammetry |
PS-06-4 |
volume |
# 086 |
volumetric imaging |
PS-24-4 |
vsop |
# 187 |
wbc scans |
# 049 |
wga-af680 |
# 102 |
wheat germ agglutinin |
# 102 |
white blood cell |
# 049 |
white matter degeneration |
PS-17-4 |
whole brain |
SG-04-3 |
whole-body |
# 225 |
whole-cell sensors |
ES-03-1 |
whooping cough |
PS-11-3 |
wnt signaling |
ES-01-5 |
wst-11 |
# 237 |
x-ray |
# 091 |
x-ray phase computed tomography |
PS-06-2 |
x-ray based lung function |
# 181 |
x-ray imaging |
PS-05-5 # 083 |
xenograft |
# 086 |
zebrafish |
PS-06-3 |
zoom tomography |
PS-05-5 |
zr-89 |
# 191 |
µct |
# 105 |
µct-derived biomarkers |
# 178 |
α-synuclein |
PS-03-2 |
fluorescence analysis |
# 069 |